HPV antigens-pulsed autologous dendritic cell vaccine (Jiangsu Antae Biological Technology)

N/A

Report date: 2025/01/26 16:01:40

Base Information

Drug NameHPV antigens-pulsed autologous dendritic cell vaccine (Jiangsu Antae Biological Technology)
Drug Alias Nameautologous dendritic cell vaccine (Jiangsu Antae)personalized autologous dendritic cell vaccine (Jiangsu Antae)
ClassificationCell and gene therapy > Cell therapyVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Antai Biotechnology Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Antai Biotechnology Company Ltd
Inactive CompaniesN/A
Active IndicationsUterine Cervical Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A